The “buy the next marijuana IPO” pitches are fast and furious these days, promising massive short-term gains as new companies go public (mostly in Canada) and try to capture the lightning in a bottle that generated bubblicious returns for speculators in past pot stock spikes (some of which have turned into hugely profitable — if […]
Articles
Upgrade service from Money Map Press’ National Institute for Cannabis Investors, focuses on providing “dossiers” and research on new marijuana companies and recommending two “IPOs” in the cannabis space per month.
Super Charge your Portfolio with these 4 High Flying cannabis IPOS… Part of the Cannabis Investors Report from Mike Ward offered for an additional $1995 membership upgrade.What are these 4 High Flying Cannabis IOPS launching any day now ! ?
Entry level research service that promises a new “Cannabis Investment Package” each month, recommending different stocks in the sector.
This article first ran on October 8, 2014. The ad is running heavily again as of early March, and remains more or less unchanged… the article below is unchanged as well. The stock teased has returned about 14% since the article first ran, roughly twice the gain of the S&P 500. Our headline today is […]
Heads up: I made a mistake on this one when it first went up on the site. We strive for at least a 99% accuracy rate in identifying teaser targets, and this is apparently my mistake for 2014. Thanks to several readers for alerting me to the fact that I moved too quickly in posting […]
Keith Fitz-Gerald and the folks at the Money Map Report are pitching something they call “Super Dividends” — payments that dwarf the typical dividend and that they say are even distinct from “special dividends.” But not content to promise big returns ($16,559 as soon as June 28, they say), they also claim that they can […]
Everyone hates taxes. Some of us don’t mind them as much as others, of course, or consider them a reasonable contribution toward common goals, but on April 15th no one who has to mail in an extra check to cover their taxes enjoys it. So the idea that you can redirect a tax, and get […]
This is really disappointing. All this time I’ve been under the impression that your friendly neighborhood Stock Gumshoe and his terrifically handsome likeness were all the “female Viagra” the world needed … but apparently some pharmaceutical companies disagree, and have been trying to develop a drug along those lines. At least, that’s the pitch from […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Interesting news release on AstraZeneca (AZN) website on ZS-9 about FDA response letter. https://www.astrazeneca.com/...
DBMD and Dr. KSS, why do you think CLVS is getting in the buy region? The results seem to be inferior to AstraZenecas dr...
$RCPT Proactiveinvestors' Philip Waller says if AstraZeneca (AZN -1.1%) doesn't get serious it will miss out on an at...
$JUNO has a new partnership with $AZN: The Juno Therapeutics Inc. (NASDAQ:JUNO) and MedImmune, the worldwide biologics ...
To Dr. KSS or anyone in the know, -Noticed BIOC bounced ever so slightly off it's interday/52 week low today. Are there...
NNRs contribute to a wide range of brain activities and influence a number of physiological functions, and in recent yea...